Bupivacaine solution (DURECT Corporation)

N/A

Report date: 2025/09/26 20:00:51

Base Information

Drug NameBupivacaine solution (DURECT Corporation)
Drug Alias NameSABER-bupivacaineBupivacaine extended release (DURECT Corporation)OptesiaPOSIDURPOSIMIR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsPain, PostoperativeHerniaAnesthesia
Global Approved IndicationsAnesthesia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/02/01
Country/TerritoryUnited StatesSwedenPoland +[11] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesDurect Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnocollHospiraDurect +[5] 
Active IndicationsN/A
Inactive IndicationsPain, PostoperativeHerniaAnesthesia

Other Information

ATC CodeN/A
Related LinksN/A